[1]
D. M. Gritenaitė, “Beyond Diabetes Mellitus and weight loss: the potential effect of GLP-1 agonist drugs in the treatment of Parkinson’s Disease”, JR, vol. 3, no. 2, pp. 159–175, May 2025.